legislation: 119-hr-7693

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
119-hr-7693	119	hr	7693	To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.		2026-02-25	2026-02-25	Referred to the House Committee on Energy and Commerce.	House	Rep. Gottheimer, Josh [D-NJ-5]	NJ	D	G000583	1		2026-02-26T09:06:58Z

Links from other tables

3 rows from bill_id in legislation_actions
0 rows from bill_id in legislation_subjects
1 row from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates